| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | Feb 14, 2024 | Kyverna Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +253,136 | 100.00% | ✗ | $5.6M |
| Apr 2, 2018 | Apr 4, 2018 | Q32 Bio Inc. | 10% Owner | Buy | 100.0 | +375,000 | 94.73% | ✗ | $6M |